Ozempic maker Novo Nordisk wants copycat products banned in Australia
The $600 billion drugmaker Novo Nordisk has become one of Europe’s largest companies off the success of its weight loss drug.
Source: afr.com
Stay updated with breaking news from Shawview Consulting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The $600 billion drugmaker Novo Nordisk has become one of Europe’s largest companies off the success of its weight loss drug.